Descovy 200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F1AV0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $67,799
Award facts
- Contract value 100% obligated
- $67,799.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $67.8K delivery order to AmerisourceBergen Drug Corp for 30-count bottles of Descovy 200-25mg tablets on January 28, 2026, with completion expected by January 29, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award represents a task order against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at up to $999.999 billion through December 2026. This prime IDC serves as a comprehensive pharmaceutical supply vehicle enabling AmerisourceBergen to deliver a broad range of medications, medical supplies, vaccines, and specialized healthcare commodities to support military healthcare programs globally.
Descovy is an antiretroviral medication used for HIV prevention and treatment, demonstrating the critical nature of pharmaceutical products procured through this contract vehicle to support military health readiness and personnel welfare. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a key vendor for federal medical procurement. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds the underlying $999.999 billion IDC with DLA extending through December 2031, underscoring the company's significant role in supplying essential pharmaceutical products across the Department of Defense healthcare enterprise.
Quick answers
Who was awarded contract SPE2DR26F1AV0?
SPE2DR26F1AV0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F1AV0 worth?
The government has obligated $67,799 on SPE2DR26F1AV0.
Is contract SPE2DR26F1AV0 an order under another contract?
Yes. SPE2DR26F1AV0 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F1AV0 competed?
The extent of competition for SPE2DR26F1AV0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award